Chronic obstructive pulmonary disease (COPD) management remains challenging due to
the high heterogeneity of clinical symptoms and the complex pathophysiological basis of the …

Telemedicine may support individual care plans in people with chronic obstructive
pulmonary disease (COPD), potentially improving the clinical outcomes. To-date there is no …

Background The clinical trial safety database for tiotropium has been augmented with a 4-
year trial in patients with COPD, which provides an opportunity to better evaluate the …

Smooth muscle cells provide crucial contractile functions in visceral, vascular, and lung
tissues. The contractile state of smooth muscle is largely determined by their electrical …

The use of bronchodilators is one of the key elements in the treatment of chronic obstructive
pulmonary disease (COPD), although there is often limited reversibility of airflow obstruction …

Introduction Projects comparing bronchodilator response by aerosol devices in the ED are
limited. Evidence suggests that the vibrating mesh nebulizer (VMN) provides 5-fold greater …

Rationale Ineffective peak inspiratory flow rate (PIFR) generation in patients using inhalers
results in insufficient drug delivery to the lungs and poor clinical outcomes. Low inspiratory …

Chronic obstructive pulmonary disease (COPD) in older adults is a complex disorder with
several unique age‐related aspects. Underlying changes in pulmonary lung function and …

Background Tiotropium is a long-acting inhaled anticholinergic developed for the treatment
of chronic obstructive pulmonary disease (COPD) and has been available since 2002. We …

Background/Aims: To evaluate the effect of Liuweibuqi capsules on chronic obstructive
pulmonary disease (COPD) through the JAK/STAT pathway. Methods: Lung function was …